Assessing the Influence of Implant Scanning Techniques on the Accuracy of Maxillary Complete-Arch Digital Scans for Implant Overdentures: A Comparative Clinical Study

December 16, 2025 updated by: Panagiotis Ntovas, National and Kapodistrian University of Athens

Evaluation of Impact of Implant Scanning Technique on the Accuracy of Maxillary Complete-arch Digital Scans for Implant-supported Overdentures

Recently different protocols have been developed for the implementation of intraoral scanning in full-arch implant workflows, as horizontal scan body scanning, 1 reverse scanning 2 and scan body systems with an integrated verification jig 3 . The aforementioned approaches are aiming to reduce the inaccuracies related with the implementation of intraoral scanners in full-arch implant cases and to improve the efficiency of the whole digital workflow. However the efficiency of these methods and the parameters that can influence their accuracy, as the design of the scan body have not been investigated.

The purpose of the present in vivo study is to compare the trueness and the precision of the recorded implant's position, between conventional and novel implant acquisition protocols.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

The collection of the clinical data for the present research is going to be performed in a private dental clinic.A single patient presenting with an edentulous maxillary arch will be enrolled in the present study.

The patient has to be treated with the placement of four implants and to be planned to be restored with an implant-supported overdenture.In total 3 different scan body systems are going to be evaluated in the present research: conventional scan-bodies (Cares Mono Scan body, Straumann), scan-bodies designed for a horizontal intraoral scanning (Apollo and Reference Scan body, Dynamic abutment), reverse scan bodies (ReveX, Straumann; Scanalog, Dynamic abutment) The scan-bodies will be hand-tightening over the multi-units, which previously will be fixed on 4 implants in patient's maxilla. Each one of the evaluated scan bodies is going to be scanned using an intraoral scanner Trios 5 (3Shape). The verified dentate scan path

recommended by the manufacturer is going to be followed, to scan the reference cast 10 times, for each one of the evaluated scan body systems. The digital scans for each group are going to be performed without removing the scan-bodies in order to eliminate the effect of scan body fit. Finally, an analog impression of splinted impression posts is going to be taken in order to serve as a reference. Based to the analog impression a reference cast is going to be fabricated using a plaster (Type 3, Moldano, Kulzer) and be scanned by a desktop scanner (T710, Medit) using laboratory scan bodies to serve as a reference.The STL files for each evaluated group along with the scans from the industrial scanner will be imported in a metrology software (Geomagic, control X). The digital model derived from each evaluated group is going to be superimposed with the model obtained from the industrial scanner respectively. In order to achieve an accurate superimposition, first "align between measured data" function will be utilized, followed by "best-fit alignment". During the alignment, the area of the scan bodies will be excluded, in order to prevent them from influencing the alignment and the subsequent evaluation. This will be accomplished by using the "use select data only" function. In order to standardize the aforementioned procedure, all superimposed models will be cut simultaneously in the same region.

Afterwards, the overall deviation will be calculated, by using "3D compare" function on Geomagic software, by creating a color map in superimposed digital models to qualitative analyze any 3D deviation. The color map is going to be ranged from -0.5mm to +0.5mm. Mean discrepancy is going to be measured in root mean square RMS, which is a mathematical measure of magnitude of a set of numbers. Trueness will be defined in terms of the mean discrepancy on the positions of the implant abutments, between the digitized by the industrial scanner reference cast and each evaluated group. Precision will be described as the standard deviation of the mean absolute discrepancies computed between the digitized by the industrial scanner reference cast and each evaluated group. A smaller SD indicates that measurements are more precise and consistent, while larger SD will imply greater variability.A power analysis was performed utilizing the G*Power software (G*Power, Heinrich- Heine-Universität Düsseldorf, Germany). The total sample size was calculated based on an effect size of 0.4, an alpha error probability of 0.05, a power of 0.8 and an estimated correlation between measurements of 0.5. The power analysis revealed that a minimum of 10 data sets per evaluated group is required to perform the present study. Statistical analysis will be performed using SPSS statistics software (version 29, IBM software).

Descriptive statistics will be calculated for each evaluated group. The Shapiro-Wilk test will be performed in order to test if the data are normally distributed (P<0.05). For the trueness and the precision, post-hoc analysis (Tukey, Scheffe) will be conducted to assess which evaluated implant acquisition technique will be statistically significantly different.

Fisher's exact test will be used to assess the association between the implant acquisition method and the accuracy of the fit. The level of significance will be set at 0.05. The agreement of fit assessment between the two experienced clinicians will be tested with κ statistics (Cohen's k-score).

Study Type

Observational

Enrollment (Estimated)

1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Dental clinical patients

Description

Inclusion Criteria:

4 implants places in fully edentelous patient that is planned to be treated with implant supported overdenture

-

Exclusion Criteria:

Diseases / Conditions That Can Contraindicate Dental Treatment

  1. Uncontrolled Systemic Conditions

    Dental procedures-especially invasive ones-are often postponed if the condition is not medically stable:

    • Uncontrolled Hypertension

    BP typically >180/110 mmHg is considered unsafe for elective dental care.

    Risk: stroke, heart attack during treatment.

    • Uncontrolled Diabetes

    High blood glucose (e.g., >300 mg/dL) increases infection risk and poor healing.

    • Uncontrolled Thyroid Disease

    Hyperthyroidism raises risk of thyroid storm, especially with epinephrine.

  2. Recent Major Cardiac Events

    Elective dental treatment is usually deferred for:

    • Heart attack (MI) within past 6 months
    • Stroke within past 6 months
    • Unstable angina
    • Severe arrhythmias
    • Decompensated heart failure

    These conditions can make dental stress or anesthesia dangerous.

  3. Infectious Diseases (Active Phase)

    Dental treatment may be delayed to protect the patient or others.

    • Active Herpetic Lesions (Cold Sores) around the mouth
    • Active Tuberculosis (TB)
    • COVID-19 or other acute respiratory infections with fever

  4. Hematologic Disorders

    If blood does not clot properly, dental surgery can be risky.

    • Severe Thrombocytopenia

    Platelets too low for safe extraction or surgery.

    • Hemophilia or bleeding disorders

    Require management with a hematologist first.

    • Patients on certain anticoagulants (e.g., warfarin with very high INR)

    May need medical adjustment before invasive care.

  5. Pregnancy (Certain Situations)

    Most dental care is safe, but some procedures are postponed:

    Elective treatments during 1st trimester

    Avoid certain medications (e.g., some anesthetics, antibiotics, NSAIDs)

    Severe hypertension or pregnancy complications (eclampsia)

  6. Severe Psychiatric Conditions (Unstable)

    When a patient cannot cooperate safely:

    Acute psychosis

    Severe anxiety uncontrolled by medication

    Need medical stabilization vs. dental sedation coordination

  7. Substance Intoxication

Dental care is not performed if patient is intoxicated with:

Alcohol

Recreational drugs (especially stimulants like cocaine or meth)

Risk of cardiovascular events or inability to consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Scan body (Conventional)
Device: Intraoral scanning
Different designs of scanbodies will be used
Scan body (Reverse design)
Device: Intraoral scanning
Different designs of scanbodies will be used
Scan body (Apollo design)
Device: Intraoral scanning
Different designs of scanbodies will be used

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Linear measurements
Time Frame: Through study completion, an average of 1 year, after the execution of all intraoral scans. (Cross-sectional)
The difference in the linear position between the control and each investigation method would be calculated.
Through study completion, an average of 1 year, after the execution of all intraoral scans. (Cross-sectional)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

National and Kapodistrian University of Athens

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

December 15, 2025

Primary Completion (Estimated)

December 25, 2025

Study Completion (Estimated)

January 15, 2026

Study Registration Dates

First Submitted

November 28, 2025

First Submitted That Met QC Criteria

December 16, 2025

First Posted (Actual)

December 22, 2025

Study Record Updates

Last Update Posted (Actual)

December 22, 2025

Last Update Submitted That Met QC Criteria

December 16, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 47/17.07.2025

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Maxillary Complete-arch Digital Scans for Implant-supported Overdentures

Clinical Trials on Intraoral scanning

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malawi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe